PC c.150C>A ;(p.I50=)

Variant ID: 11-66639329-G-T

NM_001040716.1(PC):c.150C>A;(p.I50=)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Lin28 Regulates Cancer Cell Stemness for Tumour Progression.

Cancers
Lin, Zhuohui Z; Radaeva, Mariia M; Cherkasov, Artem A; Dong, Xuesen X
Publication Date: 2022-09-24

Variant appearance in text: PC: I50=
PubMed Link: 36230562
Variant Present in the following documents:
  • cancers-14-04640.pdf
View BVdb publication page



GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits.

Neuron
Bossi, Simon S; Dhanasobhon, Dhanasak D; Ellis-Davies, Graham C R GCR; Frontera, Jimena J; de Brito Van Velze, Marcel M; Lourenço, Joana J; Murillo, Alvaro A; Luján, Rafael R; Casado, Mariano M; Perez-Otaño, Isabel I; Bacci, Alberto A; Popa, Daniela D; Paoletti, Pierre P; Rebola, Nelson N
Publication Date: 2022-08-03

Variant appearance in text: PC: I50I
PubMed Link: 35700736
Variant Present in the following documents:
  • mmc2.pdf
View BVdb publication page



Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy.

Oncotarget
Agliano, Alice A; Balarajah, Geetha G; Ciobota, Daniela M DM; Sidhu, Jasmin J; Clarke, Paul A PA; Jones, Chris C; Workman, Paul P; Leach, Martin O MO; Al-Saffar, Nada M S NMS
Publication Date: 2017-07-18

Variant appearance in text: PC: I50=
PubMed Link: 28624789
Variant Present in the following documents:
  • oncotarget-08-47969.pdf
View BVdb publication page



Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Nature Communications
Schütte, Moritz M; Risch, Thomas T; Abdavi-Azar, Nilofar N; Boehnke, Karsten K; Schumacher, Dirk D; Keil, Marlen M; Yildiriman, Reha R; Jandrasits, Christine C; Borodina, Tatiana T; Amstislavskiy, Vyacheslav V; Worth, Catherine L CL; Schweiger, Caroline C; Liebs, Sandra S; Lange, Martin M; Warnatz, Hans-Jörg HJ; Butcher, Lee M LM; Barrett, James E JE; Sultan, Marc M; Wierling, Christoph C; Golob-Schwarzl, Nicole N; Lax, Sigurd S; Uranitsch, Stefan S; Becker, Michael M; Welte, Yvonne Y; Regan, Joseph Lewis JL; Silvestrov, Maxine M; Kehler, Inge I; Fusi, Alberto A; Kessler, Thomas T; Herwig, Ralf R; Landegren, Ulf U; Wienke, Dirk D; Nilsson, Mats M; Velasco, Juan A JA; Garin-Chesa, Pilar P; Reinhard, Christoph C; Beck, Stephan S; Schäfer, Reinhold R; Regenbrecht, Christian R A CR; Henderson, David D; Lange, Bodo B; Haybaeck, Johannes J; Keilholz, Ulrich U; Hoffmann, Jens J; Lehrach, Hans H; Yaspo, Marie-Laure ML
Publication Date: 2017-02-10

Variant appearance in text: PC: I50I
PubMed Link: 28186126
Variant Present in the following documents:
  • ncomms14262-s5.xlsx, sheet 3
View BVdb publication page



Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Oncogene
Harrod, A A; Fulton, J J; Nguyen, V T M VTM; Periyasamy, M M; Ramos-Garcia, L L; Lai, C-F CF; Metodieva, G G; de Giorgio, A A; Williams, R L RL; Santos, D B DB; Gomez, P J PJ; Lin, M-L ML; Metodiev, M V MV; Stebbing, J J; Castellano, L L; Magnani, L L; Coombes, R C RC; Buluwela, L L; Ali, S S
Publication Date: 2017-04-20

Variant appearance in text: PC: I50=
PubMed Link: 27748765
Variant Present in the following documents:
  • onc2016382a.pdf
View BVdb publication page



Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5-c]quinazolines.

Scientia Pharmaceutica
Kovalenko, Sergiy I SI; Antypenko, Lyudmyla M LM; Bilyi, Andriy K AK; Kholodnyak, Sergiy V SV; Karpenko, Olexandr V OV; Antypenko, Olexii M OM; Mykhaylova, Natalya S NS; Los, Tetyana I TI; Kolomoets, Olexandra S OS
Publication Date: 2013

Variant appearance in text: PC: I50=
PubMed Link: 23833709
Variant Present in the following documents:
  • Main text
  • scipharm-2013-81-359.pdf
View BVdb publication page



Synthesis of New 6-{[ω-(Dialkylamino(heterocyclyl)alkyl]thio}-3-R-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones and Evaluation of their Anticancer and Antimicrobial Activities.

Scientia Pharmaceutica
Berest, Galina G GG; Voskoboynik, Olexiy Y OY; Kovalenko, Sergiy I SI; Nosulenko, Inna S IS; Antypenko, Lyudmyla M LM; Antypenko, Olexii M OM; Shvets, Volodymyr M VM; Katsev, Andriy M AM
Publication Date: 2012

Variant appearance in text: PC: I50=
PubMed Link: 22396903
Variant Present in the following documents:
  • scipharm-2012-80-37.pdf
View BVdb publication page